好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Asystole after VNS battery change: a case report
Epilepsy/Clinical Neurophysiology (EEG)
P1 - Poster Session 1 (9:00 AM-5:00 PM)
146
To report the second known case where patient experienced asystole after a routine VNS battery replacement.

Since its FDA approval in 1997, Vagal Nerve Stimulation has become an important therapeutic option in drug-resistant epilepsy. VNS is considered an effective and safe therapy with low rates of complications. Bradycardia and asystole have been reported in the literature with an estimated incidence of 0.1%, primarily during the intraoperative period. Asystole related to VNS is a rare complication, with only few reported cases. There has only been one other reported case where routine replacement of a VNS generator led to asystole.

The patient presented to the hospital with syncopal episodes. He was evaluated with Cardiac monitoring and Electrocardiograms along with interrogation of the VNS device. A Literature search for similar cases was performed using phrases “VNS” “Vagal Nerve Stimulator”, “Asystole” in the Pubmed search

Cardiac monitoring showed asystole corresponding with the VNS Cycles. The device was turned off and cardiology consultation was obtained. Patient was monitored in the ICU while VNS was turned on at significantly lower settings. Patients Settings before generator replacement: Output current 2.5mA, Magnet Current 2.75mA, Frequency 25Hz, Pulse Width 250ms, On-Time 30 Seconds, Off Time 1.8 minutes. Patient’s new settings after asystolic episodes: Output current 0.25mA, Magnet Current 0.375mA, Frequency 25Hz, Pulse Width 250ms, On-Time 30 Seconds, Off Time 1.8 minutes. The patient tolerated the new settings without further asystolic episodes.

Although serious adverse events are rare, bradycardia and asystole can occur during the intraoperative period primarily during initial placement of the leads. Rarely it can happen after the initial placement. Our objective is to increase physician awareness of this rare but potentially fatal complication and to share the clinical approach that was utilized. We recommend device setting adjustments and close cardiac monitoring with cardiology consultation in these cases.  

Authors/Disclosures
Animesh Gupta, MD
PRESENTER
Dr. Gupta has nothing to disclose.
LynnMarie Jarratt, MD Dr. Jarratt has nothing to disclose.